Albany, NY -- (SBWire) -- 05/22/2017 --Global Bioreactors and Fermenters Market: Overview

Bioreactors and fermenters are mainly used in research institutes and bioprocessing industries. Bioreactors are employed for the cultivation of mammalian, plants, and insect cells, and for large scale production of pharmaceuticals, antibodies, vaccines, etc., or for the bioconversion of organic wastes. Fermenters are utilized for the growth and maintenance of a population of bacterial or fungal cells in a controlled mode. They are small as compared to bioreactors. This report analyzes the current and future prospects of the bioreactors and fermenters market based on product, process, end user and geography.

Global Bioreactors and Fermenters Market: Scope of the Report

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of bioreactors used in biopharmaceutical industries, CROs, etc. in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for product, process, end user, and geography for the period 2015 to 2024. The revenue generated from product type was calculated by considering the adoption rate of bioreactors and fermenters across all geographies, number of product launched, average cost of products, trends in industry, and end user trends, among others.

Global Bioreactors and Fermenters Market: Segmentation

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product, process, end user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the bioreactors and fermenters market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved, from identification of the market need to their final reach to the end users. Furthermore, the report provides Porter's five force analysis that studies five factors and their impact on the bioreactors and fermenters market.

This exhaustive report includes 24 data tables and 63 figures to give readers a 360° view of the Bioreactors and Fermenters Market. Browse through this 182-page report to know what factors will shape the market during the period 2016-2024

http://www.transparencymarketresearch.com/bioreactors-fermenters-market.html

Global Bioreactors and Fermenters Market: Competitive Analysis

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the bioreactors and fermenters market.

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the bioreactors and fermenters market include Applikon Biotechnology B.V., Danaher Corporation, Eppendorf AG, Finesse Solutions, Inc., GE Healthcare, Merck KGaA, PBS Biotech, Inc., PIERRE GUERIN TECHNOLOGIES, Sartorius AG, SOLARIS BIOTECHNOLOGY srl, Thermo Fisher Scientific Inc and ZETA Holding GmbH. Acquisitions was the primary strategy adopted by the major market players to enter into the bioreactors and fermenters market. For instance, GE Healthcare acquired Xcellerex, Inc. in 2012, to establish its footprints in single-use bioreactors market.

The Bioreactors and Fermenters Market has been segmented as follows:

Bioreactors and Fermenters Market, by Product, Revenue (US$ Mn) 2016-2024

Single-use Bioreactors

Multiple-use Bioreactors

Bioreactors and Fermenters Market, by Process, Revenue (US$ Mn) 2016-2024

Fed batch

Continuous

Batch

Bioreactors and Fermenters Market, by End User, Revenue (US$ Mn) 2016-2024

Biopharmaceutical companies

CROs

Academic & Research Institutes

Bioreactors and Fermenters Market, by Geography, Revenue (US$ Mn), 2016-2024

North America

U.S.

Canada

Europe

U.K.

Germany

Spain

France

Italy

Rest of Europe

Latin America

Brazil

Mexico

Rest of Latin America

Asia Pacific

China

India

Japan

Australia

Rest of Asia Pacific

Middle East & Africa

U.A.E.

South Africa

Rest of Middle East & Africa

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Bioreactors and Fermenters Market during 2016- 2024

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15230